Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons

Author:

Ibrahim Karim YaqubORCID,Moreira Raquel MegaleORCID,Santos Carolina Ferreira dosORCID,Strabelli Tânia Mara VarejãoORCID,Belizário Juliana de CássiaORCID,Pinto Maria Isabel de MoraesORCID,Marinho Ana Karolina Barreto BerselliORCID,Pereira Juliana MarqueziORCID,Mello Liliane Saraiva deORCID,Ando Mauricio CesarORCID,Silva Vitor Gabriel Lopes daORCID,Sato Paula KeikoORCID,Lima Marcos Alves deORCID,França João Italo DiasORCID,Loch Ana PaulaORCID,Miyaji Karina TakesakiORCID,Infante VanessaORCID,Precioso Alexander RobertoORCID,Sartori Ana Marli ChristovamORCID

Publisher

FapUNIFESP (SciELO)

Reference33 articles.

1. Coronavirus disease (COVID-19): vaccines and vaccine safety

2. COVID-19 vaccines for low- and middle-income countries;Choi EM;Trans R Soc Trop Med Hyg,2021

3. Covid-19 booster vaccines: what we know and who's doing what;Mahase E;BMJ,2021

4. Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil;Cerqueira-Silva T;Nat Med,2022

5. Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic;Solante R;Expert Rev Vaccines,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3